Ridgetech (NASDAQ:RDGT) Upgraded to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Ridgetech (NASDAQ:RDGT) to a buy rating in a research report released on Saturday.

Separately, Weiss Ratings downgraded Ridgetech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Ridgetech Price Performance

RDGT opened at $1.56 on Friday. The company has a 50-day moving average of $129.83 and a 200-day moving average of $313.24. Ridgetech has a 1-year low of $1.23 and a 1-year high of $760.50.

Ridgetech (NASDAQ:RDGT) last issued its quarterly earnings results on Thursday, March 5th. The company reported ($0.75) EPS for the quarter. The firm had revenue of $31.40 million for the quarter.

Ridgetech Company Profile

China Jo-Jo Drugstores, Inc, together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items.